KARMILA MURPHY: Open Payments
NPI 1184234783 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 26 payments from 13 companies in 2025. Trend: 2023 $806 · 2024 $2,093 · 2025 $1,389
Food & beverage: $1,190Education: $199
| Company | Payments | Amount |
|---|---|---|
| ADC THERAPEUTICS AMERICA, INC. | 6 | $308 |
| Incyte Corporation | 5 | $284 |
| AstraZeneca Pharmaceuticals LP | 3 | $176 |
| Genentech, Inc. | 1 | $123 |
| PFIZER INC. | 1 | $119 |
| Genmab U.S., Inc. | 1 | $96 |
| Janssen Biotech, Inc. | 2 | $75 |
| Karyopharm Therapeutics Inc. | 2 | $64 |
| SOBI, INC | 1 | $34 |
| ABBVIE INC. | 1 | $32 |
Products named: ZYNLONTA, CALQUENCE, Epkinly, Tecentriq, ADCETRIS, MONJUVI, XPOVIO, TECVAYLI.
Industry payments across TX — which companies pay providers there.
